Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion description "[The cytokine LIGHT activates various anti-tumor functions through its two receptors, lymphotoxin beta receptor (LTbetaR) and herpes virus entry mediator (HVEM), and is expected to be a promising candidate for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion evidence source_evidence_literature NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion SIO_000772 20117833 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion wasDerivedFrom befree-20140225 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion wasGeneratedBy ECO_0000203 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.